1. Home
  2. AROC vs IBRX Comparison

AROC vs IBRX Comparison

Compare AROC & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Archrock Inc.

AROC

Archrock Inc.

HOLD

Current Price

$36.52

Market Cap

6.5B

Sector

Energy

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.13

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AROC
IBRX
Founded
1990
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
7.2B
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
AROC
IBRX
Price
$36.52
$7.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
7
Target Price
$40.00
$12.57
AVG Volume (30 Days)
1.6M
13.0M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
2.32%
N/A
EPS Growth
74.29
38.71
EPS
0.41
N/A
Revenue
$1,489,818,000.00
$113,288,000.00
Revenue This Year
$7.06
$88.59
Revenue Next Year
$5.27
$131.15
P/E Ratio
$87.98
N/A
Revenue Growth
28.70
668.31
52 Week Low
$21.17
$1.95
52 Week High
$40.12
$12.43

Technical Indicators

Market Signals
Indicator
AROC
IBRX
Relative Strength Index (RSI) 54.34 44.77
Support Level $34.68 $6.69
Resistance Level $37.33 $8.54
Average True Range (ATR) 1.00 0.42
MACD 0.17 -0.04
Stochastic Oscillator 74.32 23.36

Price Performance

Historical Comparison
AROC
IBRX

About AROC Archrock Inc.

Archrock Inc is an energy infrastructure company focused on midstream natural gas compression. It is a provider of natural gas compression services, based on total compression fleet horsepower, to customers across the United States and a supplier of aftermarket services to customers that own compression equipment. The company operates through two segments: contract operations and aftermarket services. The contract operations segment includes designing, sourcing, owning, installing, operating, servicing, repairing, and maintaining its owned fleet of natural gas compression equipment, and generates the maximum revenue. The aftermarket services segment provides operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: